annual EBITDA:
-$191.90M-$52.87M(-38.02%)Summary
- As of today (July 4, 2025), CLDX annual EBITDA is -$191.90 million, with the most recent change of -$52.87 million (-38.02%) on December 31, 2024.
- During the last 3 years, CLDX annual EBITDA has fallen by -$125.82 million (-190.41%).
- CLDX annual EBITDA is now -4213.63% below its all-time high of $4.67 million, reached on December 31, 2010.
Performance
CLDX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$61.87M-$6.66M(-12.07%)Summary
- As of today (July 4, 2025), CLDX quarterly EBITDA is -$61.87 million, with the most recent change of -$6.66 million (-12.07%) on March 31, 2025.
- Over the past year, CLDX quarterly EBITDA has dropped by -$22.04 million (-55.33%).
- CLDX quarterly EBITDA is now -325.50% below its all-time high of $27.44 million, reached on December 31, 2010.
Performance
CLDX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$213.94M-$22.04M(-11.48%)Summary
- As of today (July 4, 2025), CLDX TTM EBITDA is -$213.94 million, with the most recent change of -$22.04 million (-11.48%) on March 31, 2025.
- Over the past year, CLDX TTM EBITDA has dropped by -$66.82 million (-45.42%).
- CLDX TTM EBITDA is now -4687.05% below its all-time high of $4.66 million, reached on December 31, 2010.
Performance
CLDX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CLDX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.0% | -55.3% | -45.4% |
| 3 y3 years | -190.4% | -169.2% | -190.4% |
| 5 y5 years | -286.4% | -439.5% | -349.5% |
CLDX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -190.4% | at low | -129.3% | at low | -142.4% | at low |
| 5 y | 5-year | -320.4% | at low | -550.7% | at low | -368.7% | at low |
| alltime | all time | -4213.6% | at low | -325.5% | at low | -4687.1% | at low |
CLDX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$61.87M(+12.1%) | -$213.94M(+11.5%) |
| Dec 2024 | -$191.90M(+38.0%) | -$55.21M(+7.5%) | -$191.90M(+12.2%) |
| Sep 2024 | - | -$51.34M(+12.8%) | -$171.06M(+6.8%) |
| Jun 2024 | - | -$45.52M(+14.3%) | -$160.19M(+8.9%) |
| Mar 2024 | - | -$39.83M(+15.9%) | -$147.12M(+5.8%) |
| Dec 2023 | -$139.03M(+33.4%) | -$34.37M(-15.1%) | -$139.03M(+5.4%) |
| Sep 2023 | - | -$40.47M(+24.7%) | -$131.88M(+11.4%) |
| Jun 2023 | - | -$32.45M(+2.2%) | -$118.43M(+4.8%) |
| Mar 2023 | - | -$31.75M(+16.7%) | -$112.96M(+8.4%) |
| Dec 2022 | -$104.20M(+57.7%) | -$27.21M(+0.7%) | -$104.20M(+7.6%) |
| Sep 2022 | - | -$27.02M(+0.2%) | -$96.80M(+9.7%) |
| Jun 2022 | - | -$26.98M(+17.4%) | -$88.24M(+19.8%) |
| Mar 2022 | - | -$22.98M(+16.0%) | -$73.68M(+11.5%) |
| Dec 2021 | -$66.08M(+44.8%) | -$19.81M(+7.2%) | -$66.08M(+18.5%) |
| Sep 2021 | - | -$18.47M(+48.8%) | -$55.78M(+11.3%) |
| Jun 2021 | - | -$12.42M(-19.3%) | -$50.13M(+1.1%) |
| Mar 2021 | - | -$15.38M(+61.8%) | -$49.56M(+8.6%) |
| Dec 2020 | -$45.64M(-8.1%) | -$9.51M(-25.8%) | -$45.64M(-4.2%) |
| Sep 2020 | - | -$12.82M(+8.2%) | -$47.66M(+0.1%) |
| Jun 2020 | - | -$11.85M(+3.3%) | -$47.59M(-0.6%) |
| Mar 2020 | - | -$11.47M(-0.5%) | -$47.87M(-3.6%) |
| Dec 2019 | -$49.67M(-31.6%) | -$11.53M(-9.6%) | -$49.67M(-3.0%) |
| Sep 2019 | - | -$12.75M(+5.2%) | -$51.20M(-2.1%) |
| Jun 2019 | - | -$12.12M(-8.7%) | -$52.31M(-17.6%) |
| Mar 2019 | - | -$13.27M(+1.6%) | -$63.50M(-12.5%) |
| Dec 2018 | -$72.60M(-30.2%) | -$13.05M(-5.8%) | -$72.60M(-14.0%) |
| Sep 2018 | - | -$13.86M(-40.5%) | -$84.43M(-9.1%) |
| Jun 2018 | - | -$23.31M(+4.2%) | -$92.88M(-3.5%) |
| Mar 2018 | - | -$22.37M(-10.1%) | -$96.27M(-7.5%) |
| Dec 2017 | -$104.02M(-19.3%) | -$24.88M(+11.5%) | -$104.02M(-7.8%) |
| Sep 2017 | - | -$22.31M(-16.4%) | -$112.79M(-5.6%) |
| Jun 2017 | - | -$26.70M(-11.4%) | -$119.52M(-3.8%) |
| Mar 2017 | - | -$30.12M(-10.5%) | -$124.24M(-3.6%) |
| Dec 2016 | -$128.82M(+2.6%) | -$33.66M(+15.9%) | -$128.82M(+1.0%) |
| Sep 2016 | - | -$29.04M(-7.6%) | -$127.51M(-1.8%) |
| Jun 2016 | - | -$31.42M(-9.5%) | -$129.82M(-0.3%) |
| Mar 2016 | - | -$34.71M(+7.3%) | -$130.18M(+3.7%) |
| Dec 2015 | -$125.53M(+5.5%) | -$32.34M(+3.1%) | -$125.53M(+0.9%) |
| Sep 2015 | - | -$31.35M(-1.4%) | -$124.36M(+1.5%) |
| Jun 2015 | - | -$31.78M(+5.7%) | -$122.50M(+3.4%) |
| Mar 2015 | - | -$30.06M(-3.6%) | -$118.43M(-0.5%) |
| Dec 2014 | -$119.03M(+53.2%) | -$31.17M(+5.7%) | -$119.03M(+9.1%) |
| Sep 2014 | - | -$29.49M(+6.4%) | -$109.07M(+7.0%) |
| Jun 2014 | - | -$27.71M(-9.6%) | -$101.98M(+10.8%) |
| Mar 2014 | - | -$30.66M(+44.5%) | -$92.03M(+18.5%) |
| Dec 2013 | -$77.68M(+42.8%) | -$21.21M(-5.3%) | -$77.68M(+7.6%) |
| Sep 2013 | - | -$22.39M(+26.0%) | -$72.19M(+13.4%) |
| Jun 2013 | - | -$17.77M(+9.0%) | -$63.69M(+8.9%) |
| Mar 2013 | - | -$16.30M(+3.6%) | -$58.46M(+7.4%) |
| Dec 2012 | -$54.41M(+40.1%) | -$15.73M(+13.3%) | -$54.41M(+8.5%) |
| Sep 2012 | - | -$13.89M(+10.8%) | -$50.13M(+8.2%) |
| Jun 2012 | - | -$12.54M(+2.4%) | -$46.35M(+8.7%) |
| Mar 2012 | - | -$12.25M(+7.0%) | -$42.64M(+9.3%) |
| Dec 2011 | -$38.84M(-932.6%) | -$11.45M(+13.2%) | -$39.01M(>+9900.0%) |
| Sep 2011 | - | -$10.11M(+14.5%) | -$117.00K(-105.5%) |
| Jun 2011 | - | -$8.83M(+2.5%) | $2.13M(-29.8%) |
| Mar 2011 | - | -$8.61M(-131.4%) | $3.03M(-35.0%) |
| Dec 2010 | $4.67M(-114.1%) | $27.44M(-448.8%) | $4.66M(-113.6%) |
| Sep 2010 | - | -$7.87M(-0.8%) | -$34.42M(+4.3%) |
| Jun 2010 | - | -$7.93M(+13.6%) | -$32.99M(-0.1%) |
| Mar 2010 | - | -$6.98M(-40.1%) | -$33.04M(-0.1%) |
| Dec 2009 | -$33.07M(-26.2%) | -$11.65M(+80.8%) | -$33.07M(-21.1%) |
| Sep 2009 | - | -$6.44M(-19.2%) | -$41.90M(-3.1%) |
| Jun 2009 | - | -$7.98M(+13.9%) | -$43.22M(-3.5%) |
| Mar 2009 | - | -$7.00M(-65.8%) | -$44.79M(-0.0%) |
| Dec 2008 | -$44.81M(+205.2%) | -$20.48M(+163.7%) | -$44.81M(+57.6%) |
| Sep 2008 | - | -$7.76M(-18.7%) | -$28.42M(+14.6%) |
| Jun 2008 | - | -$9.55M(+36.0%) | -$24.81M(+45.3%) |
| Mar 2008 | - | -$7.02M(+71.5%) | -$17.07M(+21.5%) |
| Dec 2007 | -$14.68M(-18.0%) | -$4.09M(-1.3%) | -$14.05M(+0.2%) |
| Sep 2007 | - | -$4.15M(+128.8%) | -$14.02M(-9.4%) |
| Jun 2007 | - | -$1.81M(-54.6%) | -$15.47M(-20.6%) |
| Mar 2007 | - | -$3.99M(-1.8%) | -$19.50M(+8.9%) |
| Dec 2006 | -$17.91M(+7.0%) | -$4.07M(-27.4%) | -$17.91M(+2.4%) |
| Sep 2006 | - | -$5.60M(-4.0%) | -$17.50M(+9.5%) |
| Jun 2006 | - | -$5.83M(+142.4%) | -$15.98M(+10.5%) |
| Mar 2006 | - | -$2.41M(-34.1%) | -$14.46M(-13.6%) |
| Dec 2005 | -$16.74M | -$3.65M(-10.6%) | -$16.74M(+1.9%) |
| Sep 2005 | - | -$4.09M(-5.3%) | -$16.43M(+4.4%) |
| Jun 2005 | - | -$4.32M(-7.7%) | -$15.74M(+4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2005 | - | -$4.68M(+39.9%) | -$15.00M(+26.4%) |
| Dec 2004 | -$11.87M(+16.3%) | -$3.34M(-1.7%) | -$11.87M(+6.3%) |
| Sep 2004 | - | -$3.40M(-5.0%) | -$11.16M(+17.8%) |
| Jun 2004 | - | -$3.58M(+132.1%) | -$9.48M(+9.7%) |
| Mar 2004 | - | -$1.54M(-41.6%) | -$8.64M(-14.9%) |
| Dec 2003 | -$10.21M(-20.3%) | -$2.64M(+53.6%) | -$10.15M(-5.2%) |
| Sep 2003 | - | -$1.72M(-37.3%) | -$10.70M(+19.1%) |
| Jun 2003 | - | -$2.74M(-10.1%) | -$8.99M(-19.6%) |
| Mar 2003 | - | -$3.05M(-4.6%) | -$11.17M(-12.8%) |
| Dec 2002 | -$12.81M(-42.6%) | -$3.20M(>+9900.0%) | -$12.81M(-20.6%) |
| Sep 2002 | - | -$600.00(-100.0%) | -$16.14M(-27.2%) |
| Jun 2002 | - | -$4.93M(+5.1%) | -$22.18M(-2.9%) |
| Mar 2002 | - | -$4.69M(-28.2%) | -$22.84M(+4.1%) |
| Dec 2001 | -$22.30M(+57.8%) | -$6.53M(+8.1%) | -$21.95M(+8.4%) |
| Sep 2001 | - | -$6.04M(+8.1%) | -$20.26M(+11.0%) |
| Jun 2001 | - | -$5.59M(+47.1%) | -$18.25M(+18.9%) |
| Mar 2001 | - | -$3.80M(-21.4%) | -$15.35M(+8.6%) |
| Dec 2000 | -$14.13M(+41.9%) | -$4.83M(+20.0%) | -$14.13M(+9.1%) |
| Sep 2000 | - | -$4.03M(+49.8%) | -$12.95M(+17.5%) |
| Jun 2000 | - | -$2.69M(+4.2%) | -$11.03M(+7.2%) |
| Mar 2000 | - | -$2.58M(-29.4%) | -$10.29M(+1.8%) |
| Dec 1999 | -$9.96M(+43.3%) | -$3.66M(+74.1%) | -$10.11M(+20.3%) |
| Sep 1999 | - | -$2.10M(+7.6%) | -$8.40M(0.0%) |
| Jun 1999 | - | -$1.95M(-18.7%) | -$8.40M(+5.7%) |
| Mar 1999 | - | -$2.40M(+23.1%) | -$7.95M(+14.4%) |
| Dec 1998 | -$6.95M(-4.9%) | -$1.95M(-7.2%) | -$6.95M(+5.2%) |
| Sep 1998 | - | -$2.10M(+40.0%) | -$6.61M(+1.5%) |
| Jun 1998 | - | -$1.50M(+7.1%) | -$6.51M(-4.4%) |
| Mar 1998 | - | -$1.40M(-12.9%) | -$6.81M(-6.8%) |
| Dec 1997 | -$7.31M(-35.3%) | -$1.61M(-19.6%) | -$7.31M(-12.0%) |
| Sep 1997 | - | -$2.00M(+11.1%) | -$8.30M(-1.2%) |
| Jun 1997 | - | -$1.80M(-5.3%) | -$8.40M(-22.9%) |
| Mar 1997 | - | -$1.90M(-26.9%) | -$10.90M(-1.8%) |
| Dec 1996 | -$11.30M(+1.8%) | -$2.60M(+23.8%) | -$11.10M(-2.6%) |
| Sep 1996 | - | -$2.10M(-51.2%) | -$11.40M(-8.8%) |
| Jun 1996 | - | -$4.30M(+104.8%) | -$12.50M(+16.8%) |
| Mar 1996 | - | -$2.10M(-27.6%) | -$10.70M(-3.6%) |
| Dec 1995 | -$11.10M(+27.6%) | -$2.90M(-9.4%) | -$11.10M(+8.8%) |
| Sep 1995 | - | -$3.20M(+28.0%) | -$10.20M(+9.7%) |
| Jun 1995 | - | -$2.50M(0.0%) | -$9.30M(+1.1%) |
| Mar 1995 | - | -$2.50M(+25.0%) | -$9.20M(+4.5%) |
| Dec 1994 | -$8.70M(+2.4%) | -$2.00M(-13.0%) | -$8.80M(-1.1%) |
| Sep 1994 | - | -$2.30M(-4.2%) | -$8.90M(-1.1%) |
| Jun 1994 | - | -$2.40M(+14.3%) | -$9.00M(+7.1%) |
| Mar 1994 | - | -$2.10M(0.0%) | -$8.40M(+1.2%) |
| Dec 1993 | -$8.50M(+107.3%) | -$2.10M(-12.5%) | -$8.30M(+33.9%) |
| Sep 1993 | - | -$2.40M(+33.3%) | -$6.20M(+26.5%) |
| Jun 1993 | - | -$1.80M(-10.0%) | -$4.90M(+8.9%) |
| Mar 1993 | - | -$2.00M(+81.8%) | -$4.50M(-8.2%) |
| Dec 1992 | -$4.10M(-30.5%) | - | - |
| Oct 1992 | - | -$1.10M(-21.4%) | -$4.90M(-14.0%) |
| Jul 1992 | - | -$1.40M(-17.6%) | -$5.70M(-3.4%) |
| Apr 1992 | - | -$1.70M(+142.9%) | -$5.90M(+11.3%) |
| Apr 1992 | -$5.90M(+55.3%) | - | - |
| Jan 1992 | - | -$700.00K(-63.2%) | -$5.30M(-3.6%) |
| Oct 1991 | - | -$1.90M(+18.8%) | -$5.50M(+25.0%) |
| Jul 1991 | - | -$1.60M(+45.5%) | -$4.40M(+12.8%) |
| Apr 1991 | -$3.80M(+171.4%) | -$1.10M(+22.2%) | -$3.90M(+50.0%) |
| Jan 1991 | - | -$900.00K(+12.5%) | -$2.60M(+44.4%) |
| Oct 1990 | - | -$800.00K(-27.3%) | -$1.80M(-228.6%) |
| Jul 1990 | - | -$1.10M(-650.0%) | $1.40M(-69.6%) |
| Apr 1990 | -$1.40M(+7.7%) | $200.00K(-300.0%) | $4.60M(-270.4%) |
| Jan 1990 | - | -$100.00K(-104.2%) | -$2.70M(+285.7%) |
| Oct 1989 | - | $2.40M(+14.3%) | -$700.00K(-41.7%) |
| Jul 1989 | - | $2.10M(-129.6%) | -$1.20M(-25.0%) |
| Apr 1989 | -$1.30M(-27.8%) | -$7.10M(-473.7%) | -$1.60M(+433.3%) |
| Jan 1989 | - | $1.90M(0.0%) | -$300.00K(-57.1%) |
| Oct 1988 | - | $1.90M(+11.8%) | -$700.00K(-50.0%) |
| Jul 1988 | - | $1.70M(-129.3%) | -$1.40M(-33.3%) |
| Apr 1988 | -$1.80M(+28.6%) | -$5.80M(-486.7%) | -$2.10M(-2200.0%) |
| Jan 1988 | - | $1.50M(+25.0%) | $100.00K(-116.7%) |
| Oct 1987 | - | $1.20M(+20.0%) | -$600.00K(-50.0%) |
| Jul 1987 | - | $1.00M(-127.8%) | -$1.20M(-40.0%) |
| Apr 1987 | -$1.40M(-22.2%) | -$3.60M(-550.0%) | -$2.00M(+400.0%) |
| Jan 1987 | - | $800.00K(+33.3%) | -$400.00K(-63.6%) |
| Oct 1986 | - | $600.00K(+200.0%) | -$1.10M(-31.3%) |
| Jul 1986 | - | $200.00K(-110.0%) | -$1.60M(-5.9%) |
| Apr 1986 | -$1.80M | -$2.00M(-2100.0%) | -$1.70M(-666.7%) |
| Jan 1986 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Oct 1985 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Jul 1985 | - | $100.00K | $100.00K |
FAQ
- What is Celldex Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Celldex Therapeutics?
- What is Celldex Therapeutics annual EBITDA year-on-year change?
- What is Celldex Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly EBITDA year-on-year change?
- What is Celldex Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Celldex Therapeutics?
- What is Celldex Therapeutics TTM EBITDA year-on-year change?
What is Celldex Therapeutics annual EBITDA?
The current annual EBITDA of CLDX is -$191.90M
What is the all time high annual EBITDA for Celldex Therapeutics?
Celldex Therapeutics all-time high annual EBITDA is $4.67M
What is Celldex Therapeutics annual EBITDA year-on-year change?
Over the past year, CLDX annual EBITDA has changed by -$52.87M (-38.02%)
What is Celldex Therapeutics quarterly EBITDA?
The current quarterly EBITDA of CLDX is -$61.87M
What is the all time high quarterly EBITDA for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly EBITDA is $27.44M
What is Celldex Therapeutics quarterly EBITDA year-on-year change?
Over the past year, CLDX quarterly EBITDA has changed by -$22.04M (-55.33%)
What is Celldex Therapeutics TTM EBITDA?
The current TTM EBITDA of CLDX is -$213.94M
What is the all time high TTM EBITDA for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM EBITDA is $4.66M
What is Celldex Therapeutics TTM EBITDA year-on-year change?
Over the past year, CLDX TTM EBITDA has changed by -$66.82M (-45.42%)